ATE492547T1 - Verfahren zur herstellung lipophiler pharmazeutisch akzeptabler salze aus pemetrexed- disäure - Google Patents

Verfahren zur herstellung lipophiler pharmazeutisch akzeptabler salze aus pemetrexed- disäure

Info

Publication number
ATE492547T1
ATE492547T1 AT07836879T AT07836879T ATE492547T1 AT E492547 T1 ATE492547 T1 AT E492547T1 AT 07836879 T AT07836879 T AT 07836879T AT 07836879 T AT07836879 T AT 07836879T AT E492547 T1 ATE492547 T1 AT E492547T1
Authority
AT
Austria
Prior art keywords
pemetrexed
pharmaceutically acceptable
acceptable salts
disacid
lipophilic pharmaceutically
Prior art date
Application number
AT07836879T
Other languages
English (en)
Inventor
Jonathan Busolli
Nicola Diulgheroff
Racz Csilla Nemethne
Moran Pirkes
Alessandro Pontiroli
Marco Villa
Zvi Harel
Original Assignee
Sicor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sicor Inc filed Critical Sicor Inc
Application granted granted Critical
Publication of ATE492547T1 publication Critical patent/ATE492547T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07836879T 2006-08-14 2007-08-14 Verfahren zur herstellung lipophiler pharmazeutisch akzeptabler salze aus pemetrexed- disäure ATE492547T1 (de)

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
US83730306P 2006-08-14 2006-08-14
US83763706P 2006-08-15 2006-08-15
US83955106P 2006-08-22 2006-08-22
US84503106P 2006-09-14 2006-09-14
US84729106P 2006-09-25 2006-09-25
US85513906P 2006-10-30 2006-10-30
US86055406P 2006-11-21 2006-11-21
US86055706P 2006-11-21 2006-11-21
US88017807P 2007-01-11 2007-01-11
US88017907P 2007-01-11 2007-01-11
US89992807P 2007-02-06 2007-02-06
US93655307P 2007-06-20 2007-06-20
US95832607P 2007-07-02 2007-07-02
US95821307P 2007-07-03 2007-07-03
US95841307P 2007-07-05 2007-07-05
PCT/US2007/018098 WO2008021411A2 (en) 2006-08-14 2007-08-14 Processes for the preparation of lyophilized pharmaceutically acceptable salts of pemetrexed diacid

Publications (1)

Publication Number Publication Date
ATE492547T1 true ATE492547T1 (de) 2011-01-15

Family

ID=49584971

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07836879T ATE492547T1 (de) 2006-08-14 2007-08-14 Verfahren zur herstellung lipophiler pharmazeutisch akzeptabler salze aus pemetrexed- disäure

Country Status (9)

Country Link
US (1) US8629152B2 (de)
EP (1) EP1943252B1 (de)
JP (1) JP2008543976A (de)
KR (1) KR101083230B1 (de)
AT (1) ATE492547T1 (de)
DE (1) DE602007011384D1 (de)
ES (1) ES2356792T3 (de)
TW (1) TWI377955B (de)
WO (1) WO2008021411A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2129674A2 (de) 2007-04-03 2009-12-09 Dr. Reddy's Laboratories Ltd. Feste formen von pemetrexed
CN101684121B (zh) * 2008-09-22 2013-04-03 重庆医药工业研究院有限责任公司 培美曲塞二酸的新晶型及其制备方法
CN102838602B (zh) * 2011-06-21 2016-08-03 重庆医药工业研究院有限责任公司 培美曲塞氧化物及其制备方法
EP2854768B1 (de) 2012-05-30 2017-03-22 Fresenius Kabi Oncology Limited Pharmazeutische zusammensetzungen aus pemetrexed
EP2909208A4 (de) * 2012-10-17 2016-07-13 Shilpa Medicare Ltd Verfahren zur herstellung von pemetrexed-dikalium und dessen hydraten
KR101260636B1 (ko) * 2012-11-29 2013-05-13 씨제이제일제당 (주) 안정화된 페메트렉시드 제제
US20150359898A1 (en) 2013-02-06 2015-12-17 Cipla Limited Pemetrexed Complexes and Pharmaceutical Compositions Containing Pemetrexed Complexes
WO2014185797A1 (en) 2013-05-17 2014-11-20 Instytut Farmaceutyczny Process for the preparation of high purity amorphous pemetrexed disodium and crystalline forms of n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3- d] pyrimidin-5-yl)ethyl] benzoyl]-l-glutamic acid
US20160145260A1 (en) 2013-06-14 2016-05-26 Synthon B.V. Stable pemetrexed arginine salt and compositions comprising it
KR101703980B1 (ko) 2013-12-30 2017-02-08 주식회사 삼양바이오팜 항산화제를 함유하지 않는 약학 조성물 및 그의 제조방법
NZ630299A (en) * 2014-06-30 2014-11-28 Shilpa Medicare Ltd Pemetrexed dipotassium formulations
US20170239250A1 (en) 2016-02-19 2017-08-24 Eagle Pharmaceuticals, Inc. Pemetrexed formulations
MX2018010037A (es) * 2016-02-19 2019-07-04 Eagle Pharmaceuticals Inc Formulaciones de pemetrexed.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL96531A (en) 1989-12-11 1995-08-31 Univ Princeton History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them)
KR0162654B1 (ko) * 1989-12-11 1998-11-16 알렌 제이. 시니스갤리 N-(피롤로[2,3-d]피리미딘-3-일아크릴)-글루타민산 유도체
CA2032695A1 (en) 1989-12-20 1991-06-21 Hiroshi Akimoto Condensed heterocyclic compounds, their production and use
US5416211A (en) * 1992-09-25 1995-05-16 Eli Lilly And Company Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines
US6262262B1 (en) * 1997-09-26 2001-07-17 Eli Lilly And Company Processes and intermediates useful to make antifolates
WO2001014379A2 (en) 1999-08-23 2001-03-01 Eli Lilly And Company A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor
JP4846158B2 (ja) 2000-02-25 2011-12-28 イーライ リリー アンド カンパニー Ｎ−［４−［２−（２−アミノ−４，７−ジヒドロ−４−オキソ−３Ｈ−ピロロ［２，３−ｄ］ピリミジン−５−イル）エチル］ベンゾイル］−Ｌ−グルタミン酸の新規結晶形およびその製造方法
JP2008530216A (ja) * 2005-02-16 2008-08-07 シェーリング コーポレイション Ｃｘｃｒ３アンタゴニスト活性を有する、複素環で置換された新規のピリジンまたはフェニル化合物
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
EP2129674A2 (de) 2007-04-03 2009-12-09 Dr. Reddy's Laboratories Ltd. Feste formen von pemetrexed

Also Published As

Publication number Publication date
TWI377955B (en) 2012-12-01
KR101083230B1 (ko) 2011-11-11
WO2008021411A3 (en) 2008-04-10
DE602007011384D1 (de) 2011-02-03
WO2008021411A2 (en) 2008-02-21
KR20090035478A (ko) 2009-04-09
ES2356792T3 (es) 2011-04-13
TW200824720A (en) 2008-06-16
EP1943252A2 (de) 2008-07-16
US20080139810A1 (en) 2008-06-12
US8629152B2 (en) 2014-01-14
EP1943252B1 (de) 2010-12-22
JP2008543976A (ja) 2008-12-04

Similar Documents

Publication Publication Date Title
ATE492547T1 (de) Verfahren zur herstellung lipophiler pharmazeutisch akzeptabler salze aus pemetrexed- disäure
DE602007011843D1 (de) Verfahren zur Herstellung von Gruppe-III-Nitridkristallen
DE602006015090D1 (de) Verfahren zur herstellung von gezielt durchlässigen laminaten
ATE455105T1 (de) Verfahren zur herstellung von difluormethylpyrazolylcarboxylaten
ATE533747T1 (de) Verfahren zur herstellung von tetrahydrochinolinderivaten
ATE516816T1 (de) Verfahren zur herstellung von impfstoffen
ATE408604T1 (de) Verfahren zur herstellung von 1-alkyl-3- phenyluracilen
ATE471083T1 (de) Verfahren zur herstellung von müsliriegeln mit verbesserter konsistenz
DE602005007734D1 (de) Verfahren zur herstellung von telmisartan
ATE546436T1 (de) Verfahren zur herstellung von 2-amino-5- cyanobenzoesäurederivaten
DE502007003700D1 (de) Verfahren zur Herstellung von Glycerin
ATE523545T1 (de) Verfahren zur herstellung von polyamid
DE502006001281D1 (de) Verfahren zur herstellung substituierter biphenyle
DE502006001136D1 (de) Verfahren zur herstellung von entschäumerformulierungen
ATE480531T1 (de) Verfahren zur herstellung von benzopyran-2- olderivaten
DE602006010302D1 (de) Verfahren zur Herstellung von 5-methyl-2-furfural
ATE542808T1 (de) Verfahren zur herstellung von epichlorydrin aus glyzerin
DE602006009562D1 (de) Verfahren zur herstellung von ferrisuccinylcasein
ATE507729T1 (de) Verfahren zur herstellung von würzwürfeln
ATE554088T1 (de) Verfahren zur herstellung von pyridoä2,1- aüisochinolinderivaten
DE602007003135D1 (de) Verfahren zur Herstellung von Xylylenediamin
DE602006018182D1 (de) Verfahren zur herstellung von aralkyloxypyrrolidinderivaten
DE602007000239D1 (de) Verfahren zur Herstellung von hohlen Artikeln
DE502006002029D1 (de) Verfahren zur herstellung von polyetheraminen
ATE496871T1 (de) Verfahren zur herstellung von titanprodukten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties